IC14 in Adult Patients With Dengue Fever
NCT03875560
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
withdrawn, no enrollment
Conditions
Dengue Fever
Interventions
BIOLOGICAL:
IC14
DRUG:
Placebo
Sponsor
Implicit Bioscience